Back to Search Start Over

Lamin A/C-Related Cardiac Disease Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation

Authors :
Carlo Marcelis
Emmelien Aten
Arthur A.M. Wilde
Peter C. van den Akker
Jos L. V. Broers
Joeri A. Jansweijer
Karin Y. van Spaendonck-Zwarts
Rogier A. Oldenburg
Paul G.A. Volders
Aryan Vink
Edgar T. Hoorntje
Maarten P. van den Berg
Florence H J van Tienen
Jasper J. van der Smagt
Ilse A. E. Bollen
Jolanda van der Velden
Daniela Q.C.M. Barge-Schaapveld
Anthonie J. van Essen
Eric A. M. Hennekam
Alina Constantinescu
Arthur van den Wijngaard
J. Peter van Tintelen
Gerard J. te Meerman
Marianne Bootsma
Jan D. H. Jongbloed
Translational Immunology Groningen (TRIGR)
Cardiovascular Centre (CVC)
MUMC+: DA KG Lab Centraal Lab (9)
RS: GROW - R4 - Reproductive and Perinatal Medicine
MUMC+: MA Med Staf Spec Cardiologie (9)
RS: CARIM - R2.04 - Arrhythmogenisis and cardiogenetics
Cardiologie
Moleculaire Celbiologie
RS: GROW - R2 - Basic and Translational Cancer Biology
RS: CARIM - R2.10 - Mitochondrial disease
Physiology
ACS - Heart failure & arrhythmias
Cardiology
Graduate School
Other departments
Amsterdam Cardiovascular Sciences
Human Genetics
ACS - Pulmonary hypertension & thrombosis
Clinical Genetics
Source :
Circulation. Cardiovascular Genetics, 10, 4, pp. UNSP e001631-UNSP e001631, Circulation-Cardiovascular Genetics, 10(4):001631. LIPPINCOTT WILLIAMS & WILKINS, Circulation-Cardiovascular genetics, 10(4). Lippincott Williams and Wilkins, Circulation. Cardiovascular Genetics, 10, UNSP e001631-UNSP e001631, Circulation : Cardiovascular Genetics, 10(4):001631. LIPPINCOTT WILLIAMS & WILKINS, Circulation-cardiovascular genetics, 10(4):e001631. Lippincott Williams and Wilkins, Hoorntje, E T, Bollen, I A, Barge-Schaapveld, D Q, van Tienen, F H J, te Meerman, G J, Jansweijer, J A, van Essen, A J, Volders, P G, Constantinescu, A A, van den Akker, P C, van Spaendonck-Zwarts, K Y, Oldenburg, R A, Marcelis, C L, van der Smagt, J J, Hennekam, E A, Vink, A, Bootsma, M, Aten, E, Wilde, A A M, van den Wijngaard, A, Broers, J L, Jongbloed, J D, van der Velden, J, van den Berg, M P & van Tintelen, J P 2017, ' Lamin A/C-Related Cardiac Disease Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation ', Circulation-cardiovascular genetics, vol. 10, no. 4, e001631 . https://doi.org/10.1161/CIRCGENETICS.116.001631, Circulation. Cardiovascular genetics, 10(4):e001631. Lippincott Williams and Wilkins, Circulation: Cardiovascular Genetics, 10(4), Circulation-cardiovascular genetics, 10(4):UNSP e001631. Lippincott Williams & Wilkins
Publication Year :
2017

Abstract

Background— Interpretation of missense variants can be especially difficult when the variant is also found in control populations. This is what we encountered for the LMNA c.992G>A (p.(Arg331Gln)) variant. Therefore, to evaluate the effect of this variant, we combined an evaluation of clinical data with functional experiments and morphological studies. Methods and Results— Clinical data of 23 probands and 35 family members carrying this variant were retrospectively collected. A time-to-event analysis was performed to compare the course of the disease with carriers of other LMNA mutations. Myocardial biopsies were studied with electron microscopy and by measuring force development of the sarcomeres. Morphology of the nuclear envelope was assessed with immunofluorescence on cultured fibroblasts. The phenotype in probands and family members was characterized by atrioventricular conduction disturbances (61% and 44%, respectively), supraventricular arrhythmias (69% and 52%, respectively), and dilated cardiomyopathy (74% and 14%, respectively). LMNA p.(Arg331Gln) carriers had a significantly better outcome regarding the composite end point (malignant ventricular arrhythmias, end-stage heart failure, or death) compared with carriers of other pathogenic LMNA mutations. A shared haplotype of 1 Mb around LMNA suggested a common founder. The combined logarithm of the odds score was 3.46. Force development in membrane-permeabilized cardiomyocytes was reduced because of decreased myofibril density. Structural nuclear LMNA -associated envelope abnormalities, that is, blebs, were confirmed by electron microscopy and immunofluorescence microscopy. Conclusions— Clinical, morphological, functional, haplotype, and segregation data all indicate that LMNA p.(Arg331Gln) is a pathogenic founder mutation with a phenotype reminiscent of other LMNA mutations but with a more benign course.

Details

Language :
English
ISSN :
1942325X and 19423268
Volume :
10
Issue :
4
Database :
OpenAIRE
Journal :
Circulation-cardiovascular genetics
Accession number :
edsair.doi.dedup.....1f58eef0be6d324744d52cdf66058e46
Full Text :
https://doi.org/10.1161/circgenetics.116.001631